Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Clinical Pharmacology and Therapeutics|July 1, 1994
The pharmacodynamics of torsemide in patients with congestive heart failureD Vargo, W G Kramer, P K Black, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 2, 2002
Social support and health-related quality of life in chronic heart failure patientsS J Bennett, S M Perkins, K A Lane, et al.
Clinical Pharmacology and Therapeutics|December 1, 1985
Effect of etodolac in patients with moderate renal impairment compared with normal subjectsD C Brater, S A Anderson, D Brown-Cartwright, et al.
Cardiovascular Drugs and Therapy|January 1, 1993
Pharmacokinetics and pharmacodynamics of torasemide in patients with chronic renal insufficiency--preliminary evaluationD C Brater, D R Rudy, J R Voelker, et al.
Clinical Pharmacology and Therapeutics|June 1, 1995
Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failureD L Vargo, W G Kramer, P K Black, et al.
European Journal of Clinical Pharmacology|January 1, 1992
The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritisT S Tracy, K Krohn, D R Jones, et al.
The Journal of Pediatrics|March 1, 1982
Treatment of severe neonatal infections with cefotaxime. Efficacy and pharmacokineticsD A Kafetzis, D C Brater, A N Kapiki, et al.
Heart & Lung : the Journal of Critical Care|May 9, 2001
Reliability and validity of the compliance belief scales among patients with heart failureS J Bennett, S M Perkins, K A Lane, et al.
Clinical Pharmacology and Therapeutics|August 1, 1997
Role of duration of diuretic effect in preventing sodium retentionJ A Ferguson, K J Sundblad, P K Becker, et al.
Clinical Pharmacology and Therapeutics|March 1, 1985
A Bayesian feedback method of aminoglycoside dosingM E Burton, D C Brater, P S Chen, et al.
Pageof 15